Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05946564Phase 3Recruiting
A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
ANCA Associated VasculitisCrescentic GlomerulonephritisRapidly Progressive Glomerulonephritis
PrincipalinvestigatorStart date: 2023-10-24

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maria Antonietta D'Agostino

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Related
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

mo Wang

Children's Hospital of Chongqing Medical University

Related
1 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Patrick H Nachman, MD

UNC Kidney Center

Related
2 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Benjamin Terrier, MD, PhD

AP-HP - Service médecine interne

Related
1 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Worked with same sponsors:

Assistance Publique - Hôpitaux de Paris
Similarity Score10%

Patrick BLANCO, Prof

University Hospital, Bordeaux

Related
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Ulrich Specks, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Carol A Langford, MD, MHS

The Cleveland Clinic

Related
2 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Vimal Derebail, MD

University of North Carolina, Chapel Hill

Related
2 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Huji Xu, Ph.D, MD

Shanghai Changzheng Hospital

Related
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Philippe GUILPAIN, MD, PhD

University Hospital, Montpellier

Related
3 trials

Shared therapeutic areas:

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05946564Phase 3PrincipalInvestigator

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

ANCA Associated VasculitisCrescentic GlomerulonephritisRapidly Progressive Glomerulonephritis
Recruiting

All 1 trials loaded